JVET is an peer-reviewed, online journal, efficiently publishing original and relevant articles in thrust areas of research every month on average of 12 Issues.
Hyperbaric oxygen therapy is one of the therapeutic options added care to improve lower-limb outcomes in patients with chronic limb-threatening ischemia. Current guidelines specify that HBOT should not be offered instead of revascularization to prevent limb loss in CLTI patients.
In #patients with #heart#disease, white blood cells are more numerous. Many of these cells can be found in a plaque the buildup of fats, cholesterol & other substances in a blood vessel where they arrive after being born in the bone marrow and migrating through the #blood stream
The IU #health Southern Indiana Physicians Vascular Surgery team showed their dedication to providing the latest innovations to patients in early December by implanting a #Human#Acelluar#Vessel [HAV]. HAV is an bioengineered replacement human blood Vessel grown in Lab
#COVID19
#Peripheral artery disease is a flow-limiting condition caused by narrowing of peripheral arteries typically due to atherosclerosis It affects almost 200 million #people globally with patients either being asymptomatic or presenting with claudication or acute limb ischemia
#news
Treatment decisions can impact young adults with PAD and advanced #femoropopliteal#disease. Bypass surgery is associated with a lower reintervention rate than endovascular therapy among patients with premature peripheral artery disease (PAD) and advanced femoropopliteal disease
#Terumo#Aortic has announced the launch and first commercial case of the Aortic Balloon in the USA. The device assists physicians in expansion of aorta when using Treo and Relay stent grafts in endovascular aortic repair. The use of the product was undertaken by Siddharth Patel.
#journal of Vascular and Endovascular #Therapy#researchpaper#Title : Postraumatic Pseudoaneurysm of Common Carotid Artery After Penetrating Trauma : Diagnosis and Surgical Management
For more information of๐๐https://t.co/UuGGarZ1IW
Submit your work @ https://t.co/FZu0pHPCvO